• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本秋田县基于医院的回顾性调查研究显示,10 年间(2001-2010 年)肠套叠发病率。

Incidence of intussusception as studied from a hospital-based retrospective survey over a 10-year period (2001-2010) in Akita Prefecture, Japan.

机构信息

Department of Pediatrics, Akita University Graduate School of Medicine, Akita, Japan.

出版信息

Jpn J Infect Dis. 2012 Jul;65(4):301-5.

PMID:22814151
Abstract

One concern about rotavirus vaccines is its possible association with intussusception. Thus, it is necessary to determine the baseline incidence for intussusception in the first year of life in places where rotavirus vaccines are introduced. However, few safety data exist for the period at which the first dose of Rotarix and RotaTeq are allowed to administer in Japan. The first dose of Rotarix is scheduled to administer at 6-20 weeks of age and that of RotaTeq is scheduled to administer at 6-24 weeks of age; the upper limits for these vaccines is later than the upper limit recommended by the World Health Organization by 5 and 9 weeks, respectively. We performed a retrospective cross-sectional study by reviewing medical charts of all hospitals that provided pediatric beds in Akita Prefecture, Japan, and identifying the cases of intussusception that met the Brighton criteria level 1 in these hospitals between January 2001 and December 2010. During this 10-year period, 122 children younger than 1 year of age were diagnosed with intussusception. The incidence of intussusception was estimated at 158 per 100,000 person-years among children younger than 1 year (95% confidence interval, 131-188), 10 per 100,000 person-years for children aged 0-2 months, 165 for children aged 3-5 months, and 300 for children aged 6-8 months. This rapid and substantial increase in the incidence of intussusception during the first year of life should be considered when formulating the immunization schedule for administering rotavirus vaccines in Japan.

摘要

轮状病毒疫苗的一个担忧是其可能与肠套叠有关。因此,有必要确定轮状病毒疫苗引入地区在生命的第一年肠套叠的基础发病率。然而,在日本,Rotarix 和 RotaTeq 可以接种第一针的时期,安全数据很少。Rotarix 的第一针计划在 6-20 周龄时接种,RotaTeq 的第一针计划在 6-24 周龄时接种;这两种疫苗的上限比世界卫生组织推荐的上限分别晚了 5 周和 9 周。我们通过回顾日本秋田县所有提供儿科病床的医院的病历,对所有医院进行了回顾性横断面研究,并确定了这些医院在 2001 年 1 月至 2010 年 12 月期间符合布莱顿标准 1 级的肠套叠病例。在这 10 年期间,有 122 名年龄小于 1 岁的儿童被诊断为肠套叠。年龄小于 1 岁的儿童肠套叠发病率估计为每 100,000 人年 158 例(95%置信区间,131-188),0-2 个月儿童每 100,000 人年 10 例,3-5 个月儿童每 100,000 人年 165 例,6-8 个月儿童每 100,000 人年 300 例。在制定日本轮状病毒疫苗接种时间表时,应考虑到生命第一年肠套叠发病率的这种快速和显著增加。

相似文献

1
Incidence of intussusception as studied from a hospital-based retrospective survey over a 10-year period (2001-2010) in Akita Prefecture, Japan.日本秋田县基于医院的回顾性调查研究显示,10 年间(2001-2010 年)肠套叠发病率。
Jpn J Infect Dis. 2012 Jul;65(4):301-5.
2
A high incidence of intussusception in Japan as studied in a sentinel hospital over a 25-year period (1978-2002).在一家哨点医院对1978年至2002年这25年期间日本肠套叠高发情况的研究。
Epidemiol Infect. 2006 Feb;134(1):57-61. doi: 10.1017/S0950268805004644.
3
Intussusception surveillance in a rural demographic surveillance area in bangladesh.孟加拉国一个农村人口监测地区的肠套叠监测
J Infect Dis. 2009 Nov 1;200 Suppl 1:S271-6. doi: 10.1086/605047.
4
Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines.基于哨点儿科医院的儿童肠套叠回顾性医院监测:在轮状病毒疫苗上市后监测中应用的优缺点。
Vaccine. 2012 Apr 27;30 Suppl 1:A190-5. doi: 10.1016/j.vaccine.2011.11.015.
5
Intussusception-associated hospitalization among Venezuelan infants during 1998 through 2001: anticipating rotavirus vaccines.1998年至2001年期间委内瑞拉婴儿因肠套叠住院情况:对轮状病毒疫苗的预期
Pediatr Infect Dis J. 2003 Mar;22(3):234-9. doi: 10.1097/01.inf.0000055064.76457.f3.
6
Rotavirus infection and intussusception in Tunisian children: implications for use of attenuated rotavirus vaccines.轮状病毒感染与肠套叠在突尼斯儿童中的相关性:对使用减毒轮状病毒疫苗的影响。
J Pediatr Surg. 2009 Nov;44(11):2133-8. doi: 10.1016/j.jpedsurg.2009.05.003.
7
Intussusception following rotavirus vaccination in the Valencia Region, Spain.西班牙巴伦西亚地区轮状病毒疫苗接种后的肠套叠。
Hum Vaccin Immunother. 2015;11(7):1848-52. doi: 10.1080/21645515.2015.1049787.
8
Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?轮状病毒疫苗接种与肠套叠:我们能否通过限制疫苗接种时间表来减少与时间相关的肠套叠背景病例?
Pediatrics. 2006 Aug;118(2):e258-64. doi: 10.1542/peds.2005-2874.
9
The incidence and direct medical cost of hospitalization due to rotavirus gastroenteritis in Kyoto, Japan, as estimated from a retrospective hospital study.日本京都地区轮状病毒胃肠炎住院病例的发生率和直接医疗费用:一项回顾性医院研究评估。
Vaccine. 2011 Oct 13;29(44):7807-10. doi: 10.1016/j.vaccine.2011.07.105. Epub 2011 Aug 5.
10
Incidence of intussusception in early infancy: a capture-recapture estimate for Germany.婴儿早期肠套叠的发病率:德国的捕获-再捕获估计值
Klin Padiatr. 2011 Dec;223(7):419-23. doi: 10.1055/s-0031-1279735. Epub 2011 Jun 22.

引用本文的文献

1
The Apparent Lack of the Risk of Intussusception Immediately After Rotavirus Vaccination Among Japanese Infants.日本婴儿接种轮状病毒疫苗后短期内肠套叠风险看似不存在
Viruses. 2024 Nov 10;16(11):1758. doi: 10.3390/v16111758.
2
Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception.超过 15 年人轮状病毒疫苗(罗特律克)上市后安全性监测自发数据的综述:肠套叠。
Drug Saf. 2022 Feb;45(2):155-168. doi: 10.1007/s40264-021-01141-4. Epub 2022 Jan 11.
3
The epidemiology of childhood intussusception in South Korea: An observational study.
韩国儿童肠套叠的流行病学:一项观察性研究。
PLoS One. 2019 Dec 20;14(12):e0219286. doi: 10.1371/journal.pone.0219286. eCollection 2019.
4
Intussusception-related Hospitalizations Among Infants Before and After Private Market Licensure of Rotavirus Vaccines in Taiwan, 2001-2013.2001 - 2013年台湾轮状病毒疫苗私人市场许可前后婴儿肠套叠相关住院情况
Pediatr Infect Dis J. 2017 Oct;36(10):e252-e257. doi: 10.1097/INF.0000000000001644.
5
Assessing the risk of intussusception and rotavirus vaccine safety in Canada.评估加拿大肠套叠风险和轮状病毒疫苗安全性。
Hum Vaccin Immunother. 2017 Mar 4;13(3):703-710. doi: 10.1080/21645515.2016.1240846. Epub 2016 Nov 11.
6
Utility of hospital admission for pediatric intussusceptions.小儿肠套叠住院治疗的效用。
Pediatr Surg Int. 2016 Aug;32(8):805-9. doi: 10.1007/s00383-016-3924-z. Epub 2016 Jun 27.
7
Post-Marketing Benefit-Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis.日本轮状病毒疫苗上市后效益-风险评估:模拟与建模分析
Drug Saf. 2016 Mar;39(3):219-30. doi: 10.1007/s40264-015-0376-7.
8
Post-marketing monitoring of intussusception after rotavirus vaccination in Japan.日本轮状病毒疫苗接种后肠套叠的上市后监测。
Pharmacoepidemiol Drug Saf. 2015 Jul;24(7):765-70. doi: 10.1002/pds.3800. Epub 2015 May 27.
9
A High Incidence of Intussusception Revealed by a Retrospective Hospital-Based Study in Nha Trang, Vietnam between 2009 and 2011.一项基于越南芽庄市医院的回顾性研究揭示了2009年至2011年间肠套叠的高发病率。
Trop Med Health. 2013 Sep;41(3):121-7. doi: 10.2149/tmh.2013-09. Epub 2013 Aug 20.
10
Intussusception incidence among infants in the UK and Republic of Ireland: a pre-rotavirus vaccine prospective surveillance study.英国和爱尔兰共和国婴儿肠套叠发病率:轮状病毒疫苗前前瞻性监测研究。
Vaccine. 2013 Aug 28;31(38):4098-102. doi: 10.1016/j.vaccine.2013.06.084. Epub 2013 Jul 17.